The only way to overcome the challenges facing the medicines supply chain in the UK is through close cooperation - the government, pharmacies, and the
industry all working together in tandem - said Andrew Stephenson, Minister for Health and Social Care.
The MP for Pendle, Lancashire made the statement while addressing the Healthcare Distribution Association's (HDA) Annual Conference at the Institute of Directors
in Pall Mall, London on Thursday (25 January), where over 130 leaders from the pharma industry gathered.
As the keynote speaker, Stephenson acknowledged the crucial role wholesalers, manufacturers, and retail pharmacy chains, play in the wellbeing of the nation.
He said: "In the first few months that I've been in this job, it's become immediately obvious to me just how important this sector is and just how important the
work that all of you do is for our country."
AAH Pharmaceuticals (AAH) has announced the appointment of Brain Chambers as Chief Commercial Officer.
"I'm proud to lead the commercial functions in AAH in my new role and broader area of responsibility." Said Brian. "I'm committed to delivering on great value for
our customers and building and strengthening our supplier partnerships."
Brain is associated with AAH Pharmaceuticals for more than 14 years. He joined the organisation as Business Development Manager in October 2008. His previous role
in the organisation was on Sales and Marketing Director.
He posted on LinkedIn: "This is a big move for me personally, but that's a side hustle. What is the main play here is AAH becoming a standalone independent wholesale
business focussed on only the AAH customer and our core business and this is just one part of that.
The Competition and Markets Authority(CMA) has disqualified a former director of the pharmaceutical wholesaler Lexon for allegedly breaking competition law.
Pritesh Sonpal - who has been accused of illegally sharing commercially sensitive information with competitors - will not be allowed to take up any director role or be involved in the management of any company based in England, Scotland or Wales for four years.
The CMA in March 2020 found that Lexon - along with the pharmaceutical companies King Pharmaceuticals and Alissa Healthcare Research - illegally shared commercially
sensitive information about the antidepressant nortriptyline, used by thousands of NHS patients, to inflate the price.
Lexon was fined £1.2 million for breaking competition law.
The government watchdog said between 2015 and 2017, when the cost of the drug was falling, the three companies exchanged information about prices, the volumes they were supplying and Alissa's plans to enter the market, in order to reduce competition.
Southwark Crown Court on Thursday sentenced two pharmacists to two years of imprisonment each, suspended for 24 months, after they were found guilty of
selling 'industrial' quantities of Class C controlled drugs.
Mandip Sidhu (47) of Littleover, Derby and Nabeil Nasr (42) of Cheadle, Greater Manchester, pleaded guilty at an earlier hearing following an investigation by
the Criminal Enforcement Unit of the Medicines and Healthcare Products Regulatory Authority (MHRA).
Both Sidhu and Nasr were pharmacists registered with the General Pharmaceutical Council at the time of the offenses, which took place between May 2013 and
June 2017. Sidhu was the director of Pharmaceutical Health Limited (PHL) in Derby, while Nasr owned several pharmacies across the North West of England.
Sidhu was sentenced to two years imprisonment on each of five counts of supplying Class C drugs and four months for forgery, all to run concurrently and suspended
for 24 months. Additionally, she must complete 200 hours of community service for her role in the illegal supply of diazepam, zolpidem, and zopiclone.